U.S. pharma big copyright scrapped two experimental weight loss products past year—a as soon as-each day pill, lotiglipron, on account of elevated liver enzymes along with a twice-day by day capsule, danuglipron, on account of strong Uncomfortable side effects—but CEO Albert Bourla h